Blot WJ: Esophageal cancer trends and risk factors. Semin Oncol. 1994, 21: 403-10.
CAS
PubMed
Google Scholar
Smans M, Muir CS, Boyle P, Smans M, Muir CS, Boyle P, editors: Atlas of cancer mortality in the EEC. Lyon: International agency for research on cancer. 1992
Mathews HR, Waterhouse JAH, Powell J, McConkey CC, Robertson JE, Editors: Cancer of the oesophagus. Clinical cancer monographs vol. 1987, London: Macmillan
Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer statistics, 2001. CA Cancer J Clin. 2001, 51: 15-36.
Article
CAS
PubMed
Google Scholar
Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW: Aspirin use and risk of fatal cancer. Cancer Res. 1993, 53 (6): 1322-7.
CAS
PubMed
Google Scholar
Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992, 89 (16): 7384-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vane J: Towards a better Aspirin. Nature. 1994, 367: 215-6. 10.1038/367215a0.
Article
CAS
PubMed
Google Scholar
Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D: Selective expression of mitogen inducible cyclooxygenase in macrophages stimulated with lipopolysacharide. J Biol Chem. 1992, 267: 25934-8.
CAS
PubMed
Google Scholar
Sakamoto C, Matsuda K, Nakano O, Konda Y, Matozaki T, Nishisaki H, Kasuga M: EGF stimulates both cyclooxygenase activity and cell proliferation in cultured guinea pig gastric mucus cells. J Gastroenterol. 1994, 29 (7): 73-6.
CAS
PubMed
Google Scholar
Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM: Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 1993, 268 (12): 9049-54.
CAS
PubMed
Google Scholar
Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF: Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology. 1998, 115 (2): 297-306. 10.1016/S0016-5085(98)70196-9.
Article
CAS
PubMed
Google Scholar
Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994, 107 (4): 1183-8.
Article
CAS
PubMed
Google Scholar
Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M: Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 1997, 57: 1276-1280.
CAS
PubMed
Google Scholar
Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T, Sata M: Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology. 1999, 29 (3): 688-96. 10.1002/hep.510290355.
Article
CAS
PubMed
Google Scholar
Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 1999, 59 (5): 987-90.
CAS
PubMed
Google Scholar
Wilson KT, Fu S, Ramanujam KS, Meltzer SJ: Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 1998, 58 (14): 2929-2934.
CAS
PubMed
Google Scholar
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM: Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996, 87 (5): 803-9. 10.1016/S0092-8674(00)81988-1.
Article
CAS
PubMed
Google Scholar
Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000, 342 (26): 1946-52. 10.1056/NEJM200006293422603.
Article
CAS
PubMed
Google Scholar
Kawamori T, Rao CV, Seibert K, Reddy BS: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, againstcolo carcinogenesis. Cancer Res. 1998, 58 (3): 409-12.
CAS
PubMed
Google Scholar
Hara A, Yoshimi N, Niwa M, Ino N, Mori H: Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn J Cancer Res. 1997, 88 (6): 600-4.
Article
CAS
PubMed
Google Scholar
Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M: Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab invest. 1999, 79 (12): 1469-77.
CAS
PubMed
Google Scholar
Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M: Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol. 1998, 274: 1061-1067.
Google Scholar
Buskens CJ, Van Rees BP, Sivula A, Reitsma JB, Haglund C, Bosma PJ, Offerhaus GJ, van Lanschot JJ, Ristimaki A: Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology. 2002, 122 (7): 1800-7. 10.1053/gast.2002.33580.
Article
CAS
PubMed
Google Scholar
Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, Yano M, Inoue M, Matsuura N, Shiozaki H, Monden M: Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res. 2000, 6 (4): 1229-38.
CAS
PubMed
Google Scholar
Nozoe T, Ezaki T, Kabashima A, Baba H, Kabashima A: Significance of immunohistochemical expression of COX-2 in squamous cell carcinoma of the esophagus. Am J Surg. 2005, 189 (1): 110-5. 10.1016/j.amjsurg.2004.03.019.
Article
CAS
PubMed
Google Scholar
France M, Drew PA, Dodd T, Watson DI: Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinicaloutcome following esophagectomy. Dis Esophagus. 2004, 17 (2): 136-40. 10.1111/j.1442-2050.2004.00390.x.
Article
CAS
PubMed
Google Scholar
Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS, McCarty KS: Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Reseach. 1989, 49 (4): 1052-6.
CAS
Google Scholar
Bhandari P, Bateman AC, Mehta RL, Patel P: Mucosal expression of cylooxygenase isoforms 1 and 2 is increased with worsening damage to the gastric mucosa. Histopathology. 2005, 46: 280-86. 10.1111/j.1365-2559.2005.02053.x.
Article
CAS
PubMed
Google Scholar
Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ: Selective inhibition of cylooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Research . 2000, 60: 5767-72.
CAS
PubMed
Google Scholar
Reddy BS, Rao CV, Seibert K: Evaluation of COX-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Research. 1996, 56: 4566-69.
CAS
PubMed
Google Scholar
Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998, 93: 705-16. 10.1016/S0092-8674(00)81433-6.
Article
CAS
PubMed
Google Scholar
Dohadwala M, Batra RK, Luo J, Lin Y, Krysan K, Pold M, Sharma S, Dubinett SM: Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cox-2 dependent invasion. J Biol Chem. 2002, 277 (52): 50828-33. 10.1074/jbc.M210707200.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tomozawa S, Nagawa H, Tsuno N, Hatano K, Osada T, Kitayama J, Sunami E, Nita ME, Ishihara S, Yano H, Tsuruo T, Shibata Y, Muto T: Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer. 1999, 81: 1274-79. 10.1038/sj.bjc.6694262.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lagorce C, Paraf F, Vidaud D, Couverlard A, Wendum D, Martin A, Flejou J-F: Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma. Histopatholog. 2003, 2: 457-65. 10.1046/j.1365-2559.2003.01627.x.
Article
Google Scholar